Thus, we examined the impact of AQCH drug substance treatment in the secondary dengue AG129 model on serum viremia as well as markers of small intestinal pathology, viz., viral load, vascular leakage, and TNF-α and IL-6 levels. This evidence concerns the gene IL6 and dengue disease.